v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Loss for the year $ (26,492) $ (7,279) $ (19,977)
Adjustments:      
Depreciation 203 186 197
Impairment loss 20,482 202
Finance income, net (966) (3,726) (2,294)
Share-based payments 309 582 1,875
Total adjustments (6,464) (10,035) (20,199)
Changes in assets and liabilities:      
Changes in other current assets 153 96 178
Changes in trade payables 450 (2,076) 1,334
Changes in other payables 205 (2,352) (1,076)
Changes in post-employment benefit liabilities (162)
Changes in assets and liabilities, total 808 (4,332) 274
Net cash used in operating activities (5,656) (14,367) (19,925)
Cash flows from investing activities:      
Acquisition of subsidiary, net of cash acquired (see Note 4C) (3,549)
Proceed from other investments 458 187 875
Decrease (increase) in short term deposits (9) 2 15,803
Interest received 186 320 755
Acquisition of fixed assets (3) (3)
Net cash provided by investing activities 632 509 13,881
Cash flows from financing activities:      
Proceeds from issuance of ADSs 3,153 5,809 1,563
ADS issuance expenses paid (312) (556) (229)
Proceeds from issuance of warrants and prefunded warrants 4,240 5,000
Proceeds from warrant inducement transaction 2,028
Warrants issuance expenses paid (508) (280) (661)
Repayment of lease liability (217) (183) (168)
Interest paid (23) (44) (56)
Net cash provided by financing activities 6,333 6,774 5,449
Net increase (decrease) in cash and cash equivalents 1,309 (7,084) (595)
Cash and cash equivalents at the beginning of the year 7,401 14,489 15,030
Effect of translation adjustments on cash and cash equivalents 7 (4) 54
Cash and cash equivalents at end of the year $ 8,717 $ 7,401 $ 14,489